1. Home
  2. AVNS vs ARDX Comparison

AVNS vs ARDX Comparison

Compare AVNS & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avanos Medical Inc.

AVNS

Avanos Medical Inc.

HOLD

Current Price

$24.80

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$6.67

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVNS
ARDX
Founded
2014
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
AVNS
ARDX
Price
$24.80
$6.67
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$15.14
AVG Volume (30 Days)
2.0M
4.0M
Earning Date
05-04-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
81.59
N/A
EPS
0.11
N/A
Revenue
$701,200,000.00
$2,607,000.00
Revenue This Year
$3.28
$37.75
Revenue Next Year
$4.23
$34.24
P/E Ratio
$225.41
N/A
Revenue Growth
1.95
N/A
52 Week Low
$9.30
$3.54
52 Week High
$24.81
$8.40

Technical Indicators

Market Signals
Indicator
AVNS
ARDX
Relative Strength Index (RSI) 90.70 55.41
Support Level $12.75 $5.54
Resistance Level N/A $7.43
Average True Range (ATR) 0.07 0.36
MACD -0.33 0.05
Stochastic Oscillator 64.52 52.48

Price Performance

Historical Comparison
AVNS
ARDX

About AVNS Avanos Medical Inc.

Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: